Zentalis Pharmaceuticals Llc Stock Price History
| ZNTL Stock | USD 3.63 0.15 4.31% |
Below is the normalized historical share price chart for Zentalis Pharmaceuticals Llc extending back to April 03, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zentalis Pharmaceuticals stands at 3.63, as last reported on the 28th of November, with the highest price reaching 3.70 and the lowest price hitting 3.54 during the day.
If you're considering investing in Zentalis Stock, it is important to understand the factors that can impact its price. Zentalis Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Zentalis Pharmaceuticals shows Sharpe Ratio of 0.0402, which attests that the company had a 0.0402% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Zentalis Pharmaceuticals, which you can use to evaluate the volatility of the company. Please utilize Zentalis Pharmaceuticals' Market Risk Adjusted Performance of 0.1657, downside deviation of 5.44, and Mean Deviation of 4.2 to validate if our risk estimates are consistent with your expectations.
The value of Total Stockholder Equity is estimated to slide to about 306.3 M. The value of Common Stock Total Equity is estimated to slide to about 50.4 K. The value of Price To Sales Ratio is estimated to slide to about 23.9 K. The value of Price Earnings Ratio is estimated to slide to -3.56. Zentalis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of April 2020 | 200 Day MA 7.6099 | 50 Day MA 3.401 | Beta 1.742 |
Zentalis |
Sharpe Ratio = 0.0402
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZNTL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.86 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Zentalis Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zentalis Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.6999 | Enterprise Value Ebitda (2.31) | Price Sales 6.378 | Shares Float 51.1 M | Wall Street Target Price 9.5 |
Zentalis Pharmaceuticals Stock Price History Chart
There are several ways to analyze Zentalis Stock price data. The simplest method is using a basic Zentalis candlestick price chart, which shows Zentalis Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 19, 2024 | 4.36 |
| Lowest Price | October 30, 2024 | 2.7 |
Zentalis Pharmaceuticals November 28, 2024 Stock Price Synopsis
Various analyses of Zentalis Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Zentalis Stock. It can be used to describe the percentage change in the price of Zentalis Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Zentalis Stock.| Zentalis Pharmaceuticals Price Rate Of Daily Change | 1.04 | |
| Zentalis Pharmaceuticals Price Action Indicator | 0.08 | |
| Zentalis Pharmaceuticals Price Daily Balance Of Power | 0.94 |
Zentalis Pharmaceuticals November 28, 2024 Stock Price Analysis
Zentalis Stock Price History Data
The price series of Zentalis Pharmaceuticals for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.66 with a coefficient of variation of 12.18. The daily prices for the period are distributed with arithmetic mean of 3.38. The median price for the last 90 days is 3.25.| Open | High | Low | Close | Volume | ||
11/28/2024 | 3.56 | 3.70 | 3.54 | 3.63 | ||
| 11/27/2024 | 3.56 | 3.70 | 3.54 | 3.63 | 544,587 | |
| 11/26/2024 | 3.47 | 3.55 | 3.38 | 3.48 | 535,657 | |
| 11/25/2024 | 3.33 | 3.60 | 3.28 | 3.50 | 869,834 | |
| 11/22/2024 | 3.20 | 3.42 | 3.08 | 3.23 | 1,165,033 | |
| 11/21/2024 | 3.12 | 3.25 | 2.99 | 3.18 | 1,086,656 | |
| 11/20/2024 | 3.01 | 3.20 | 2.90 | 3.13 | 1,192,225 | |
| 11/19/2024 | 3.06 | 3.07 | 2.91 | 2.99 | 1,149,111 | |
| 11/18/2024 | 3.48 | 3.48 | 3.00 | 3.05 | 1,200,648 | |
| 11/15/2024 | 3.99 | 4.00 | 3.36 | 3.47 | 1,831,666 | |
| 11/14/2024 | 3.97 | 4.16 | 3.90 | 3.95 | 1,348,944 | |
| 11/13/2024 | 4.00 | 4.44 | 3.89 | 3.92 | 2,225,405 | |
| 11/12/2024 | 4.00 | 4.14 | 3.65 | 3.71 | 898,315 | |
| 11/11/2024 | 4.01 | 4.13 | 3.89 | 4.03 | 1,278,607 | |
| 11/08/2024 | 3.85 | 4.05 | 3.77 | 3.96 | 1,452,498 | |
| 11/07/2024 | 3.87 | 4.12 | 3.77 | 3.81 | 1,312,995 | |
| 11/06/2024 | 3.90 | 4.17 | 3.65 | 3.84 | 1,313,029 | |
| 11/05/2024 | 3.62 | 3.80 | 3.46 | 3.78 | 1,293,126 | |
| 11/04/2024 | 3.25 | 4.07 | 3.19 | 3.73 | 2,852,483 | |
| 11/01/2024 | 2.74 | 3.34 | 2.71 | 3.32 | 2,814,684 | |
| 10/31/2024 | 2.67 | 2.93 | 2.66 | 2.73 | 2,300,798 | |
| 10/30/2024 | 2.81 | 2.86 | 2.67 | 2.70 | 1,368,074 | |
| 10/29/2024 | 2.83 | 2.92 | 2.75 | 2.84 | 2,097,582 | |
| 10/28/2024 | 2.85 | 3.02 | 2.82 | 2.83 | 773,500 | |
| 10/25/2024 | 3.10 | 3.10 | 2.82 | 2.83 | 1,235,983 | |
| 10/24/2024 | 3.31 | 3.38 | 3.07 | 3.10 | 985,521 | |
| 10/23/2024 | 3.09 | 3.38 | 3.04 | 3.32 | 1,259,860 | |
| 10/22/2024 | 3.17 | 3.21 | 3.07 | 3.12 | 580,106 | |
| 10/21/2024 | 3.15 | 3.23 | 3.03 | 3.20 | 1,178,431 | |
| 10/18/2024 | 2.99 | 3.15 | 2.96 | 3.14 | 1,699,250 | |
| 10/17/2024 | 2.99 | 3.02 | 2.92 | 3.00 | 869,006 | |
| 10/16/2024 | 2.96 | 3.04 | 2.93 | 2.98 | 1,325,543 | |
| 10/15/2024 | 2.95 | 3.06 | 2.89 | 2.94 | 790,601 | |
| 10/14/2024 | 2.97 | 3.04 | 2.94 | 2.96 | 1,522,146 | |
| 10/11/2024 | 2.94 | 3.10 | 2.92 | 2.99 | 1,121,674 | |
| 10/10/2024 | 2.93 | 3.00 | 2.89 | 2.94 | 846,431 | |
| 10/09/2024 | 3.03 | 3.07 | 2.94 | 3.01 | 853,571 | |
| 10/08/2024 | 3.09 | 3.14 | 3.02 | 3.04 | 1,092,378 | |
| 10/07/2024 | 3.26 | 3.26 | 3.07 | 3.11 | 720,061 | |
| 10/04/2024 | 3.24 | 3.49 | 3.09 | 3.37 | 1,217,703 | |
| 10/03/2024 | 3.30 | 3.34 | 3.16 | 3.20 | 1,998,869 | |
| 10/02/2024 | 3.54 | 3.55 | 3.35 | 3.35 | 816,219 | |
| 10/01/2024 | 3.65 | 3.67 | 3.42 | 3.57 | 1,264,787 | |
| 09/30/2024 | 3.70 | 3.78 | 3.60 | 3.68 | 698,069 | |
| 09/27/2024 | 3.76 | 3.95 | 3.73 | 3.75 | 784,757 | |
| 09/26/2024 | 3.86 | 3.86 | 3.64 | 3.69 | 1,150,064 | |
| 09/25/2024 | 4.01 | 4.01 | 3.76 | 3.76 | 1,247,096 | |
| 09/24/2024 | 4.12 | 4.14 | 3.85 | 4.02 | 1,325,242 | |
| 09/23/2024 | 4.17 | 4.19 | 4.00 | 4.06 | 1,386,879 | |
| 09/20/2024 | 4.30 | 4.35 | 4.03 | 4.22 | 4,451,570 | |
| 09/19/2024 | 4.32 | 4.46 | 4.21 | 4.36 | 1,973,434 | |
| 09/18/2024 | 4.10 | 4.35 | 4.00 | 4.16 | 2,421,638 | |
| 09/17/2024 | 3.75 | 4.39 | 3.75 | 4.10 | 7,267,925 | |
| 09/16/2024 | 5.00 | 5.44 | 3.65 | 3.68 | 44,546,097 | |
| 09/13/2024 | 3.18 | 3.41 | 3.17 | 3.24 | 521,590 | |
| 09/12/2024 | 3.27 | 3.27 | 3.13 | 3.15 | 409,414 | |
| 09/11/2024 | 3.24 | 3.25 | 3.15 | 3.25 | 410,873 | |
| 09/10/2024 | 3.03 | 3.28 | 3.00 | 3.27 | 685,503 | |
| 09/09/2024 | 2.97 | 3.16 | 2.97 | 3.03 | 907,866 | |
| 09/06/2024 | 3.25 | 3.32 | 2.95 | 2.96 | 748,156 | |
| 09/05/2024 | 3.25 | 3.30 | 3.19 | 3.24 | 345,384 |
About Zentalis Pharmaceuticals Stock history
Zentalis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zentalis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zentalis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zentalis Pharmaceuticals stock prices may prove useful in developing a viable investing in Zentalis Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.4 M | 46.9 M | |
| Net Loss | -213.1 M | -202.5 M |
Zentalis Pharmaceuticals Quarterly Net Working Capital |
|
Zentalis Pharmaceuticals Stock Technical Analysis
Zentalis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Zentalis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zentalis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Zentalis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zentalis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0648 | |||
| Jensen Alpha | 0.1087 | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.056 | |||
| Treynor Ratio | 0.1557 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis Pharmaceuticals Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.61) | Revenue Per Share 0.572 | Return On Assets (0.25) | Return On Equity (0.43) |
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.